Circumvention of TKI resistance with HDAC inhibitors in lung cancer

被引：0
|
作者：
Yano, Seiji [1 ]
机构：
[1] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 9201192, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
JS1-5
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] APOBEC3B and TKI resistance in EGFR mutant lung cancer.
    Caswell, Deborah
    Mayekar, Manasi
    Law, Emily
    Hill, William
    Gronroos, Eva
    Harris, Reuben
    Bivona, Trever
    Swanton, Charles
    CANCER RESEARCH, 2021, 81 (13)
  • [32] Management of Resistance to EGFR TKI-Targeted Therapy of Lung Cancer: Lessons in Monitoring Cancer Evolution
    Dudek, Arkadiusz Z.
    ONCOLOGY-NEW YORK, 2016, 30 (07): : 616 - 618
  • [33] HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer
    Biersack, Bernhard
    Nitzsche, Bianca
    Hoepfner, Michael
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 64 - 79
  • [34] TAXOL RESISTANCE IN PROSTATE CANCER: RESCUE OF RESISTANCE AND EXPRESSION OF PROSTATE CANCER-ASSOCIATED GENES UPON TREATMENT WITH HDAC INHIBITORS
    Christudass, Christhunesa
    Sood, Karan
    Yeater, David
    Getzenberg, Robert
    Veltri, Robert
    JOURNAL OF UROLOGY, 2012, 187 (04): : E323 - E323
  • [35] Circumvention of multidrug resistance
    Nooter, K
    Stoter, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 302 - 302
  • [36] The glycoprotein inhibitors overcome the resistance of the topoisomerase inhibitors in small cell lung cancer
    Noro, Rintaro
    Omori, Miwako
    Fukuizumi, Aya
    Matsuda, Kuniko
    Hirao, Mariko
    Takahashi, Satoshi
    Takano, Natsuki
    Nakamichi, Shinji
    Sugano, Teppei
    Miyanaga, Akihiko
    Minegishi, Yuji
    Seike, Masahiro
    Kubota, Kaoru
    Gemma, Akihiko
    CANCER RESEARCH, 2020, 80 (16)
  • [37] HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
    Stockhammer, Paul
    Ho, Cassandra Su Lyn
    Hegedus, Luca
    Lotz, Gabor
    Molnar, Eszter
    Bankfalvi, Agnes
    Herold, Thomas
    Kalbourtzis, Stavros
    Ploenes, Till
    Eberhardt, Wilfried E. E.
    Schuler, Martin
    Aigner, Clemens
    Schramm, Alexander
    Hegedus, Balazs
    LUNG CANCER, 2020, 144 : 20 - 29
  • [38] Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer
    Roy, Rubi
    Ria, Tasnim
    RoyMahaPatra, Debapriya
    Sk, Ugir Hossain
    ACS OMEGA, 2023, 8 (19): : 16532 - 16544
  • [39] Advances in nanobiotechnology-propelled multidrug resistance circumvention of cancer
    Chen, Jie
    Yu, Xin
    Liu, Xinyu
    Ni, Jinliang
    Yang, Guangcan
    Zhang, Kun
    NANOSCALE, 2022, 14 (36) : 12984 - 12998
  • [40] New therapeutic strategies for overcoming resistance to targeted drugs in lung cancer by HDAC inhibition
    Takeuchi, Shinji
    CANCER SCIENCE, 2018, 109 : 141 - 141
12345